
Mark Rosenbaum
Examiner (ID: 3538, Phone: (571)272-4523 , Office: P/3725 )
| Most Active Art Unit | 3725 |
| Art Unit(s) | 3201, 3202, 3103, 3206, 3725, 3203, 3209, 3204, 2899, 3502, 3505 |
| Total Applications | 4526 |
| Issued Applications | 3830 |
| Pending Applications | 109 |
| Abandoned Applications | 597 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17790448
[patent_doc_number] => 20220249539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/587743
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/587743 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | Jan 27, 2022 | Abandoned |
Array
(
[id] => 19049414
[patent_doc_number] => 20240091383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SYNERGISTIC EFFECT OF SMN1 AND MIR-23A IN TREATING SPINAL MUSCULAR ATROPHY
[patent_app_type] => utility
[patent_app_number] => 18/274496
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274496
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274496 | SYNERGISTIC EFFECT OF SMN1 AND MIR-23A IN TREATING SPINAL MUSCULAR ATROPHY | Jan 27, 2022 | Pending |
Array
(
[id] => 17748017
[patent_doc_number] => 20220226220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITION FOR PREVENTING GRAY HAIR, PROMOTING BLACK HAIR AND PREVENTING, IMPROVING OR TREATING VITILIGO OR HYPOCHROMATISM COMPRISING FRUCTOSE 1,6-BISPHOSPHATE OR SALT, SOLVATE, STEREOISOMER OR HYDRATE THEREOF AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/578949
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578949 | Composition for preventing gray hair, promoting black hair and preventing, improving or treating vitiligo or hypochromatism comprising fructose 1,6-bisphosphate or salt, solvate, stereoisomer or hydrate thereof as active ingredient | Jan 18, 2022 | Issued |
Array
(
[id] => 19477528
[patent_doc_number] => 20240325570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => TREATING DISEASES AND IMPROVING NUCLEIC ACID DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/271536
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271536 | TREATING DISEASES AND IMPROVING NUCLEIC ACID DELIVERY | Jan 13, 2022 | Pending |
Array
(
[id] => 17561551
[patent_doc_number] => 20220125700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => BIO-DEGRADABLE MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/570498
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570498 | BIO-DEGRADABLE MICROCAPSULES | Jan 6, 2022 | Pending |
Array
(
[id] => 18871099
[patent_doc_number] => 11858884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Compositions and methods for modulating gene or gene product in cells
[patent_app_type] => utility
[patent_app_number] => 17/566666
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 48
[patent_no_of_words] => 32623
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17566666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/566666 | Compositions and methods for modulating gene or gene product in cells | Dec 29, 2021 | Issued |
Array
(
[id] => 19125695
[patent_doc_number] => 20240131048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => MICELLAR NANOPARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/259618
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -108
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259618
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259618 | MICELLAR NANOPARTICLES AND USES THEREOF | Dec 28, 2021 | Pending |
Array
(
[id] => 19884274
[patent_doc_number] => 12269967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Methods for making antifouling materials
[patent_app_type] => utility
[patent_app_number] => 17/564399
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7249
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17564399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/564399 | Methods for making antifouling materials | Dec 28, 2021 | Issued |
Array
(
[id] => 18469037
[patent_doc_number] => 20230203321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => ANTIFOULING MATERIALS
[patent_app_type] => utility
[patent_app_number] => 17/564405
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17564405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/564405 | ANTIFOULING MATERIALS | Dec 28, 2021 | Abandoned |
Array
(
[id] => 18466849
[patent_doc_number] => 20230201129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => ELECTROSPUN FIBROUS MATRIX, ITS PREPARATION METHOD AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/564096
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17564096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/564096 | Electrospun fibrous matrix, its preparation method and uses thereof | Dec 27, 2021 | Issued |
Array
(
[id] => 18903038
[patent_doc_number] => 20240018523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY
[patent_app_type] => utility
[patent_app_number] => 18/037960
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -67
[patent_words_short_claim] => 351
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037960
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037960 | GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY | Dec 20, 2021 | Pending |
Array
(
[id] => 19034485
[patent_doc_number] => 20240084300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => MIRNA COMPOSITION COMPRISING 11 SPECIFIC MIRNAS AND ITS USE IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/268450
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268450
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/268450 | MIRNA COMPOSITION COMPRISING 11 SPECIFIC MIRNAS AND ITS USE IN THE TREATMENT OF CANCER | Dec 19, 2021 | Pending |
Array
(
[id] => 17851818
[patent_doc_number] => 20220281860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/644986
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644986
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/644986 | COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES | Dec 16, 2021 | Abandoned |
Array
(
[id] => 17928202
[patent_doc_number] => 20220323327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => METHODS FOR TREATING RELAXED HAIR
[patent_app_type] => utility
[patent_app_number] => 17/542112
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542112
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/542112 | Methods for treating relaxed hair | Dec 2, 2021 | Issued |
Array
(
[id] => 17640725
[patent_doc_number] => 20220168463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => ENHANCED PERFORMANCE SOLUTION FOR TISSUE GRAFTS
[patent_app_type] => utility
[patent_app_number] => 17/538733
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17538733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/538733 | ENHANCED PERFORMANCE SOLUTION FOR TISSUE GRAFTS | Nov 29, 2021 | Abandoned |
Array
(
[id] => 17624933
[patent_doc_number] => 20220159948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => Antimicrobial and Antiviral Paper Products Including Silver Ions
[patent_app_type] => utility
[patent_app_number] => 17/534777
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/534777 | Antimicrobial and Antiviral Paper Products Including Silver Ions | Nov 23, 2021 | Abandoned |
Array
(
[id] => 18862298
[patent_doc_number] => 20230416734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => UMLILO ANTISENSE TRANSCRIPTION INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/037234
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037234
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037234 | UMLILO ANTISENSE TRANSCRIPTION INHIBITORS | Nov 16, 2021 | Pending |
Array
(
[id] => 19896892
[patent_doc_number] => 12274788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Particulate poly(lactic-co-glycolic) acid, method for manufacturing particulate poly (lactic-co-glycolic) acid, and particulate poly(lactic-co-glycolic) acid manufacturing apparatus
[patent_app_type] => utility
[patent_app_number] => 17/525521
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6409
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525521 | Particulate poly(lactic-co-glycolic) acid, method for manufacturing particulate poly (lactic-co-glycolic) acid, and particulate poly(lactic-co-glycolic) acid manufacturing apparatus | Nov 11, 2021 | Issued |
Array
(
[id] => 18938222
[patent_doc_number] => 20240033361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => NEUTRALIZABLE COVALENT DRUG
[patent_app_type] => utility
[patent_app_number] => 18/265458
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265458
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265458 | NEUTRALIZABLE COVALENT DRUG | Oct 27, 2021 | Pending |
Array
(
[id] => 17561684
[patent_doc_number] => 20220125833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => VITAMIN D COMPOSITIONS AND METHODS OF USE IN THE TREATMENT OF COVID-19 AND OTHER LIPID ENVELOPED VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/451843
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17451843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/451843 | VITAMIN D COMPOSITIONS AND METHODS OF USE IN THE TREATMENT OF COVID-19 AND OTHER LIPID ENVELOPED VIRAL INFECTIONS | Oct 21, 2021 | Abandoned |